Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related TEVA
Teva Announces Positive Results for TEV-48125 in Phase IIb Chronic Migraine Study Meeting Primary and Secondary Endpoints
Stocks Hitting 52-Week Highs
Teva divests manufacturing site as part of cost reduction plan (Seeking Alpha)
Related JASO
Axiom Capital: Chinese Solar Sector 'Ripe' For Shorting
Wild Swings In Solar Short Interest

Analysts at Morgan Stanley upgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “underweight” to “equal-weight.” The price target for Teva Pharmaceutical is set to $52. Teva Pharmaceutical's shares closed at $47.96 yesterday.

Axiom upgraded JA Solar Holdings Co (NASDAQ: JASO) from “undefined” to “buy.” The price target for JA Solar is set to $16. JA Solar's shares closed at $10.55 yesterday.

Analysts at Keefe Bruyette & Woods upgraded Independent Bank (NASDAQ: INDB) from “market perform” to “outperform.” The price target for Independent Bank has been raised from $40 to $44. Independent Bank's shares closed at $38.11 yesterday.

Oppenheimer upgraded Lowe's Companies (NYSE: LOW) from “market perform” to “outperform.” The price target for Lowe's Companies has been raised from $50 to $57. Lowe's shares closed at $48.71 yesterday.

Latest Ratings for TEVA

DateFirmActionFromTo
Jan 2015JefferiesMaintainsBuy
Dec 2014Sterne AgeeUpgradesNeutralBuy
Dec 2014Deutsche BankMaintainsBuy

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (INDB + JASO)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga PRO content